Barbara Mroczko Selected Research

Tissue Inhibitor of Metalloproteinase-2

4/2014	Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients.
4/2012	The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
1/2012	Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
1/2011	Clinical significance of serum levels of matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor (TIMP-2) in gastric cancer.
12/2010	Matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in the diagnosis of colorectal adenoma and cancer patients.
7/2010	[Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors TIMP-1 and TIMP-2 in children treated for acute lymphoblastic leukemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Mroczko Research Topics

Disease

68	Neoplasms (Cancer) 05/2022 - 01/2002
26	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2013
26	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 01/2002
23	Neoplasm Metastasis (Metastasis) 03/2022 - 04/2008
18	Dementia (Dementias) 01/2022 - 01/2013
14	Inflammation (Inflammations) 05/2022 - 01/2008
14	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 03/2004
13	Stomach Neoplasms (Stomach Cancer) 10/2021 - 12/2006
12	Cognitive Dysfunction 01/2022 - 01/2014
11	Esophageal Neoplasms (Esophageal Cancer) 10/2017 - 01/2008
10	Carcinogenesis 05/2022 - 07/2004
8	Adenoma (Adenomas) 05/2021 - 09/2006
7	Multiple Sclerosis 04/2022 - 11/2008
7	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2013
7	Breast Neoplasms (Breast Cancer) 05/2007 - 01/2003
6	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 09/2021 - 01/2011
5	Infections 01/2022 - 01/2011
5	Pancreatitis 06/2015 - 01/2003
5	Hypertension (High Blood Pressure) 10/2010 - 03/2004
4	Meningitis 01/2022 - 01/2011
4	Myocardial Infarction 02/2019 - 03/2004
4	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016 - 03/2008
4	ST Elevation Myocardial Infarction 01/2011 - 11/2006
4	Chronic Pancreatitis 01/2010 - 03/2004
3	COVID-19 05/2022 - 06/2021
3	Virus Diseases (Viral Diseases) 05/2022 - 11/2014
3	Disease Progression 04/2022 - 07/2004
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2022 - 11/2014
3	Neuroinflammatory Diseases 01/2022 - 01/2017
3	Intrahepatic Cholestasis of Pregnancy 01/2022 - 04/2020
3	Carcinoma (Carcinomatosis) 08/2021 - 01/2019
3	Lung Neoplasms (Lung Cancer) 07/2020 - 01/2002
3	Sepsis (Septicemia) 05/2019 - 11/2008
3	Lymphatic Metastasis 01/2019 - 05/2007
3	Amyloid Plaque 01/2018 - 01/2013
3	Asthma (Bronchial Asthma) 01/2010 - 01/2008
2	Parkinson Disease (Parkinson's Disease) 04/2022 - 01/2021
2	Liver Diseases (Liver Disease) 01/2022 - 04/2020
2	Meningoencephalitis 01/2022 - 03/2019
2	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 03/2019
2	Glioma (Gliomas) 06/2021 - 05/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 05/2007
2	Septic Shock (Toxic Shock Syndrome) 05/2019 - 08/2018
2	Leukocytosis (Pleocytosis) 03/2019 - 07/2010
2	Fibrosis (Cirrhosis) 01/2019 - 12/2015

Drug/Important Bio-Agent (IBA)

51	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2008
34	Tumor Biomarkers (Tumor Markers)IBA 10/2021 - 01/2002
26	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2010
25	Matrix Metalloproteinases (MMPs)IBA 09/2021 - 03/2008
20	ChemokinesIBA 03/2022 - 08/2015
19	CytokinesIBA 03/2022 - 04/2002
19	C-Reactive ProteinIBA 03/2021 - 07/2002
15	Carcinoembryonic AntigenIBA 03/2021 - 04/2002
13	EnzymesIBA 01/2022 - 02/2004
12	Macrophage Colony-Stimulating FactorIBA 05/2021 - 04/2002
12	AntigensIBA 01/2016 - 04/2002
10	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2014
10	CarbohydratesIBA 01/2020 - 04/2002
9	Tissue Inhibitor of Metalloproteinase-1IBA 05/2021 - 01/2009
9	Interleukin-6 (Interleukin 6)IBA 05/2019 - 05/2007
9	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019 - 01/2008
8	Metalloproteases (Metalloproteinases)IBA 05/2022 - 04/2008
6	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2022 - 08/2009
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2021 - 05/2003
6	Stem Cell FactorIBA 10/2017 - 05/2003
6	Tissue Inhibitor of Metalloproteinase-2IBA 04/2014 - 07/2010
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2007 - 04/2002
5	LigandsIBA 03/2022 - 12/2010
5	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2014
5	Amyloid beta-PeptidesIBA 01/2022 - 01/2017
5	tau Proteins (tau Protein)IBA 01/2022 - 01/2017
5	IsoenzymesIBA 01/2022 - 08/2009
5	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2019 - 12/2010
5	squamous cell carcinoma-related antigenIBA 01/2016 - 03/2008
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2015 - 01/2007
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2007 - 05/2003
5	Interleukin-3 (Interleukin 3)IBA 01/2007 - 05/2003
4	MicroRNAs (MicroRNA)IBA 04/2022 - 02/2019
4	Aldehyde DehydrogenaseIBA 07/2020 - 08/2009
4	Collagen Type IV (Type IV Collagen)IBA 03/2016 - 01/2008
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2011 - 11/2006
3	diazonaphthalenedisulfonic acid (NDS)IBA 04/2022 - 01/2018
3	AntibodiesIBA 01/2022 - 04/2012
3	Immunoglobulins (Immunoglobulin)IBA 09/2021 - 05/2020
3	LipidsIBA 07/2021 - 03/2004
3	Biological ProductsIBA 06/2021 - 03/2020
3	Vitamin D-Binding ProteinIBA 08/2018 - 11/2008
2	DisintegrinsIBA 05/2022 - 09/2021
2	Interleukin-8B ReceptorsIBA 10/2021 - 01/2018
2	NeurograninIBA 10/2021 - 11/2020
2	Chemokine ReceptorsIBA 11/2020 - 05/2020
2	NeurocalcinIBA 11/2020 - 01/2015
2	Immunoglobulin G (IgG)IBA 05/2020 - 04/2012
2	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2020 - 05/2007
2	SeleniumIBA 07/2019 - 04/2004
2	Glutathione PeroxidaseIBA 07/2019 - 04/2004
2	ProcalcitoninIBA 05/2019 - 08/2018
2	Triggering Receptor Expressed on Myeloid Cells-1IBA 05/2019 - 08/2018

Therapy/Procedure

12	Therapeutics 05/2022 - 05/2007
3	Drug Therapy (Chemotherapy) 01/2006 - 07/2004